Axial Biotech, Transgenomic deal

Transgenomic completed its acquisition of assets and IP related to Axial's ScoliScore Adolescent Idiopathic Scoliosis (AIS) Prognostic Test for about $4.4 million in cash (see BioCentury, Sept. 3). ...